Increase access to oral contraception by letting pharmacist do their jobs

The Pharmaceutical Society of Australia (PSA) calls on the Therapeutic Goods Administration (TGA) to improve access to oral contraception.

 

Under the ‘continued dispensing’ arrangements in place due to the COVID-19 pandemic, pharmacists have been safely dispensing oral contraceptives to patients who have previously been prescribed the medicine without a current prescription. The pandemic aside, Australian pharmacists have an eight-year track record of supplying oral contractive pills under continued dispensing arrangements, demonstrating their competence in continuing to perform this activity.

 

Yesterday, the TGA announced an interim decision which will revert to pre-pandemic arrangements, once again limiting a woman’s ability to access to oral contraceptives without a prescription through Australian pharmacies.

 

PSA National President, A/Prof Chris Freeman, said:

 

“This interim decision is very disappointing, and we will be responding to the TGA to reconsider their position before making a final decision. The benefits of improved access to oral contraception are clear. Well-established models exist overseas, where pharmacists can provide the medicine once it has previously been prescribed.

 

“Predictably, the Australian doctors’ lobby groups are more worried about ‘protecting their own turf’, than providing women with timely, cheaper and safe access to contraception. The public are sick of it. The AMA don’t bat an eyelid when it comes to fringe online prescription services but are comfortable in restricting access for Australian pharmacists.

 

“We have already seen the success of continued dispensing of oral contraceptives through the pandemic, and internationally, there are well-established models which demonstrate the success of pharmacists’ role in this process.

 

“We respect the TGA’s process and will continue to work closely with them over the coming weeks in order to improve access to medicines,” A/Prof Freeman said.

 

Dr Fei Sim, Chair of the PSA’s Contemporary Community Pharmacy Practice Community of Specialty Interest (CCPP-CSI), said:

 

“It is very disappointing to see the AMA and RACGP continue advocating to restrict women’s access to the oral contraceptive pill. To say that this decision preserves safe access to this critical medicine is ludicrous – one that does not take into consideration the best interests of patients. As Australia’s most accessible health care providers, pharmacists are ideally placed to support patients to access this critical medicine.

 

“Time is quite literally of the essence when patients are seeking access to contraception, therefore, we must have a process in place that enables safe access to such medication, without the red tape. When it comes to contraception, it is imperative that we have a patient-centric approach, one that Australian women need and deserve.

 

“The same rhetoric we saw in the initial stages of pharmacists providing immunisations has now resurfaced, whereby, doctors’ groups advocated against immunisations being administered by pharmacists for the same hollow reason they want to restrict access to contraception. Now, pharmacists’ true impact on the COVID rollout has been demonstrated by administering over 1.3 million COVID-19 vaccinations,” Dr Sim said.

 

 

Media contact: PSA media 0424 777 463

PSA welcomes WA vaccine mandate for health workers

The Pharmaceutical Society of Australia (PSA) welcomes the McGowan Government’s announcement that COVID-19 vaccinations will become mandatory for primary and community health workers.

 

Yesterday, the WA Health Minister announced that to attend their workplace, health care workers will be required to be vaccinated against COVID-19. This will protect health care workers and their patients, and will mitigate the risk of further transmission through primary care setting like pharmacies and general practice.

 

From 1 November, in order to enter these worksites, a worker must have received their first dose of the vaccine, with the second dose to be received by 1 December.

 

PSA WA Branch President, Keegan Wong, said: “PSA applauds the McGowan Government’s decision to mandate the COVID-19 vaccine for the West’s frontline health workers, demonstrating their commitment to protecting our community.

 

“It is imperative that Western Australians have the confidence that these settings, and those who work within, are compliant with the health advice. We cannot have a situation where vulnerable members of the community remain anxious about contracting this disease through clinical settings like pharmacies and hospitals, especially as we learn to live alongside it.

 

“This move will protect our staff, patients, consumers and the community at large and we are glad to see that the state has followed Victoria and Tasmania’s lead on this front.

 

“Whilst this is good news for the state, we also recognise those extenuating circumstances where health workers have genuine medical contraindications to vaccination – and PSA is reassured a process exists to support this very small cohort,” Mr Wong concluded.

 

 

Media contact: PSA media 0424 777 463

PSA welcomes the ACT’s commitment to pill testing

The Pharmaceutical Society of Australia (PSA) welcomes the ACT Government’s commitment to harm minimisation by funding a pilot for a fixed-site pill testing service.

 

This week’s ACT Budget provides funding for a six-month pilot program which will support the harm minimisation initiative, pill testing. This service provides analysis of the content of illicit drugs, warning users about unknown and potentially lethal contaminants.

 

PSA considers pill testing and drug checking to be consistent with the principles of harm reduction and supports further trials to inform the role of pill testing and drug checking within Australia. PSA believes that these trials should occur both at music festivals and also within or near other environments where illicit drug use occurs.

 

PSA ACT Branch President, Renae Beardmore, applauded the Barr Government’s commitment.

 

“It is great to see that tackling the highly-controversial topic of pill testing remains on the Chief Minister’s agenda. Illicit drug use is an incredibly complex and challenging issue for our community, and contributes significantly to the total burden of disease and injury in Australia.

 

“Pill testing and drug checking aims to provide consumers with credible information about the risks of consuming particular substances. The intent of pill testing and drug checking is not to provide the impression the tested substances are safe, as they remain illegal and potentially very harmful.

 

“PSA supports Australia’s commitment to harm minimisation as outlined in the National Drug Strategy. This includes support for initiatives which reduce demand, reduce harm and reduce supply of illicit drugs.

 

“Such services have been trialled and tested across European countries such as the Netherlands, Austria, Portugal and France – providing conclusive evidence that pill testing saves lives. Here in Canberra, pill testing has been trialled at Groovin the Moo music festival in 2018 and 2019 – this saw patrons, who had dangerous drugs identified, dispose of the drugs in amnesty bins. In the 2019 trial, 28 percent of patrons noted that they would use less of the drug than initially intended. These results attest to the findings of these European country.

 

“As medicine safety experts, pharmacists can have a key role in this intervention and in the provision of such advice. Pharmacists have a long and established role in harm minimisation, from Opioid Replacement Therapy and needle and syringe programs, to providing naloxone over the counter. Pharmacists also have extensive experience in handling restricted substances.

 

“There are many ACT pharmacists that work in the harm minimisation space and some have the particular skillset that would make them perfect for involvement in trials and subsequent implementation of ongoing pill testing and drug checking services.

 

“By providing tailored support and information on drug use and associated harms, consumers will be empowered to make informed decisions when considering use of a substance.

 

“Law enforcement by itself does not stop people from dying, and in some cases can exacerbate outcomes from drug consumption – but pill testing, as a supplementary strategy, can. PSA looks forward to providing support to ACT Health in rolling out this initiative,” Ms Beardmore said.

 

 

Media contact: PSA media 0424 777 463

1 million COVID-19 jabs administered by pharmacists!

According to today’s data from the Australian Immunisation Register (AIR), 1 million COVID-19 vaccines have now been administered by pharmacists since community pharmacists started administering vaccines.

 

PSA National President, A/Prof Chris Freeman, said that pharmacists are key to getting Australia’s vaccination rates over the line.

 

“Today, pharmacists have achieved yet another milestone in the vaccine rollout, administering more than 1 million COVID-19 vaccinations to Australians.

 

“Pharmacist immunisers have been the key to bolstering vaccination rates across the country, and community pharmacy has managed the surge in demand brilliantly. This patient-centric approach is evidently paying dividends, with states like NSW and ACT now within touching distance of life-after-lockdown.

 

“Just yesterday, almost 40,000 vaccines were administered by pharmacists, a staggering achievement. It is apparent that increased vaccine choice and greater accessibility is having a positive impact amongst the community.

 

“To all those pharmacists who have remained open beyond business hours and on weekends in order to vaccinate their communities, I thank you – but moreover, Australia thanks you.

 

“Local pharmacies have fridges full of both AstraZeneca and Moderna vaccines, so I encourage all who remain unvaccinated to book in for their vaccination with their local pharmacist,” A/Prof Freeman said.

 

PSA is dedicated to supporting pharmacists in delivering all COVID-19 vaccines both safely and effectively to the public.

 

Last week, 1^st October, national eligibility for Moderna was expanded to include those aged over 60 years, offering greater vaccine choice and access to mRNA through pharmacies.

 

 

Media contact: PSA media 0424 777 463

Victorian antigen tests welcomed by PSA – more needed

The Pharmaceutical Society of Australia (PSA) welcomes the Victorian Government’s move to secure additional rapid antigen tests (RAT) for hospitals. However, government-funded routine RAT for community pharmacies is essential to ensure continuity of essential health services.

 

Yesterday, the Victorian Government announced they will secure 2.2 million rapid antigen tests for the Victorian health system, most of which are likely to be utilised through the hospital sector.

 

PSA Victorian Branch President, John Jackson, commended the move and called for government-funded rapid antigen testing for community pharmacists and their staff to be prioritised.

 

“We welcome the Victorian Government’s commitment to the funding of rapid antigen testing for hospitals. The provision of RAT will help protect Victoria’s hospitals workers, including pharmacists.

 

“Whilst this is welcomed news for the hospital sector and the pharmacists who work in hospitals, there is urgent need for antigen testing in our local pharmacies. On what seems to be a daily basis, pharmacies are being listed as exposure sites across locked down states. As a result, these pharmacies are required to close, and staff forced to isolate – we cannot afford further closures and must protect the health and wellbeing of Australia’s most accessible health care workforce, pharmacists,” Mr Jackson said.

 

PSA National President, A/Prof Chris Freeman, said: “Rapid antigen testing would allow community pharmacies to bring their workforce back sooner. Returned in less than 15 minutes, negative rapid antigen tests will provide health authorities and community pharmacies with the confidence to reopen sooner, ensuring their communities continue to have access to essential medicines and health services such as vaccinations.

 

“At a quarter of the cost of a PCR test, rapid antigen testing must form a major part of the country’s COVID-19 response – allowing asymptomatic staff to be tested quickly, ensuring a safer workplace and maintaining community access to medicines and services.

 

“Now that Australians are seeing light at the end of the lockdown tunnel, how we manage this disease and future outbreaks will be the real challenge. Rapid antigen testing must be a cornerstone of life beyond COVID-19 – it will play a crucial role in limiting targeted lockdowns and protecting society’s most vulnerable,” A/Prof Freeman said.

 

 

 

Media contact: PSA media 0424 777 463

PSA welcomes mandatory vaccination of Victorian health workers

The Pharmaceutical Society of Australia (PSA) welcomes the Victorian Government’s decision to mandate COVID-19 vaccination for the state’s frontline health workers.

 

Last night, Victoria’s Acting Chief Health Officer signed public health orders requiring all people who work in a health care setting to be vaccinated against COVID-19. The order applies to community pharmacy, hospitals, general practice and more.

 

From 15 October, in order to enter these worksites, a worker must have received their first dose of the vaccine by 15 October and 15 December for dose two.

 

PSA Victorian Branch President, John Jackson, applauded the move.

 

“As the state navigates its way out of its sixth lockdown and grapples a safe reopening, this is a step in the right direction. It protects health care workers. It protects patients. It further reduces the risk of further transmission through high-risk primary care settings.

 

“All health care workers and the community should be able to have confidence that everyone working to support health has heeded the health advice. That is, being vaccinated to protect themselves, their colleagues, and their patients.

 

“We also acknowledge the small cohort of health workers who have genuine medical contraindication to vaccination and welcome provisions to support people who have rare, but genuine, contraindications to vaccination,” Mr Jackson said.

 

PSA calls on all state and territory governments to mandate COVID-19 vaccinations for all health workers – including those working in primary care such as community pharmacies.

 

 

 

Media contact: PSA media 0424 777 463

PSA releases Guidelines for Pharmacists Providing Smoking Cessation Support

In December 2020, the Therapeutic Goods Administration (TGA) announced that from today, 1^st October 2021, a prescription will be required to access liquid nicotine for inhalation (vaping), following a change to its scheduling.

 

To manage these legislative changes, the Pharmaceutical Society of Australia (PSA), with support from the Commonwealth Department of Health, has developed guidelines and education to support Australian pharmacists through the transition.

 

Claire Antrobus, Manager, Practice Support and project lead, explained why such support is required.

 

“From today, a prescription will be required to access nicotine vaping products. When nicotine vaping products are prescribed under the Authorised Prescriber Scheme or the Special Access Scheme they can be dispensed through local pharmacies.

 

“As a result of these legislative changes, we are likely to see patients presenting to pharmacies, to access nicotine vaping products via prescription. PSA has worked with the Therapeutic Goods Administration, the Department of Health’s Tobacco Control Section, Quit Victoria, the Royal Australian College of General Practitioners, the National Aboriginal Community Controlled Health Organisation, the Pharmacy Guild of Australia and the Royal Australian and New Zealand College of Psychiatrists to develop guidelines and education which equips pharmacists with the skills and knowledge to effectively manage the transition.

 

“These guidelines outline the pharmacist’s role in providing smoking cessation support and key requirements for dispensing nicotine vaping products, including counselling and safety considerations.

 

“There are currently no nicotine vaping products registered on the Australian Register of Therapeutic Goods, so access to these unapproved therapeutic goods will occur via the Special Access Scheme, Authorised Prescriber Scheme or Personal Importation Scheme pathway.

 

“These guidelines provide information for pharmacists about the key considerations for supporting patients to stop smoking, including the special considerations for nicotine vaping products,” Ms Antrobus said.

 

On Wednesday night, PSA hosted a smoking cessation webinar for members – detailing the role in which pharmacists will be required to fulfil when their patients seek smoking cessation advice. Upon completion, pharmacists will receive CPD credits. The recorded session can be accessed via this link.

 

To access the Guidelines for Pharmacists Providing Smoking Cessation Support, please visit this link. Further information is also available on the TGA website.

 

PSA, in collaboration with Quit Victoria, has developed two education modules to support pharmacists:

 

https://my.psa.org.au/s/training-plan/a110o00000E66Wc/smoking-cessation-brief-advice-training-for-pharmacists-part-1

 

https://my.psa.org.au/s/training-plan/a110o00000E66Uc/dispensing-nicotine-vaping-products-part-2

 

The Royal Australian College of General Practitioners have also updated their Stop Smoking Guidelines to support the transition. These can be found here.

 

 

Media contact: PSA media 0424 777 463

World Pharmacists Day – Pharmacists: Always trusted for your health

Today marks World Pharmacists Day, providing an opportunity to recognise and celebrate the incredible work and dedication of our pharmacists, both nationally and abroad.

 

This year’s theme is Pharmacists: Always trusted for your health, and over the past week, PSA has been shining a spotlight on a variety of different practice areas and highlighting the many roles that pharmacists are trusted to fulfil.

 

PSA National Vice President, Renae Beardmore, reflected on the past year and praised the efforts of Australia’s most accessible healthcare workforce. 

 

“Pharmacists across the country have done an incredible job continuing to put the health and welfare of their patients and communities first, amidst increasingly difficult circumstances. On behalf of the PSA, I thank you.

 

“Our profession is an essential cog in the Australian healthcare system, and as an essential service, has been called upon by governments and the public to protect society’s most vulnerable. 

 

“In the face of adversity resulting from the COVID-19 pandemic and the aftermath of the 2019/20 bushfires, our pharmacists have remained accessible, approachable and have gone above and beyond to ensure that patients have had the care that they need, when they need it.

 

“You have stepped up once again to help expedite the vaccine rollout, which is now starting to pay significant dividends across the country – helping the nation achieve its vaccination targets. Pharmacists have now administered over 600,000 COVID-19 vaccines to Australians through pharmacies, hospitals, general practice, and Aboriginal and Community Controlled Health Organisations (ACCHOs). A remarkable achievement in such a short space of time. 

 

“PSA has been with you every step of the way, by ensuring that you are equipped with the knowledge, skills and resources required to help your patients and the community at large. None of this would be possible without our members – we need you to stand behind the Society in achieving the outcomes we all want, and that our patients need and deserve.

 

“Pharmacists practising to full scope and being remunerated appropriately for not only the sacrifices made, but the expertise and attention to detail that the role requires, must be acknowledged and supported by governments and policy makers,” Ms Beardmore concluded. 

 

PSA also marked World Pharmacists Day by holding the 2021 PSA Viatris Awards Ceremony last night, to recognise some of our outstanding pharmacists for their high standards, professionalism, and commitment to the profession. 

 

Ms Beardmore proudly congratulated the 2021 award winners for their excellence in and devotion to Australian pharmacy. 

 

“Year on year, it is becoming more challenging for our judges to decide on the winners of these prestigious awards – an indication of just how promising the future of pharmacy really is.

 

“These pharmacists are exemplars to the profession and maintained the highest standards of commitment and professionalism – and I congratulate them on their outstanding efforts over the past 12 months, particularly in the face of the ongoing COVID-19 pandemic.

 

“You have all stepped up when your patients and communities have needed you the most. You have had to contend with public panic, anxiety, constantly changing regulations, medicine shortages and unfortunately in some cases, abusive behaviour. On behalf of the PSA and Australia, I thank you.”

 

The 2021 PSA Excellence Awards winners are:

• Viatris Pharmacy Student of the Year Award – Zoe Robinson, QLD
• MIMS Intern Pharmacist of the Year – Erin Cooper, ACT
• Symbion Early Career Pharmacist of the Year – Maria Berbecaru, TAS
• Symbion Pharmacist of the Year – Linda Badewitz-Dodd, NSW
• Symbion Lifetime Achievement Award – Valerie Constable, VIC
• Symbion Lifetime Achievement Award (Posthumous) – John Ware OAM, VIC

 

PSA CEO, Mark Kinsela, thanked the Award’s sponsors for their ongoing support.

 

“I would like to thank Viatris, Symbion and MIMS for once again sponsoring these awards in recognition of Australia’s exceptional pharmacists, and Viatris for helping the PSA to deliver such a wonderful virtual event in the face of COVID-19 restrictions.

 

“These longstanding partnerships demonstrate how critical the pharmacy profession is to our country’s healthcare system, acknowledging excellence across the entire spectrum of pharmacy practice,” Mr Kinsela said.

 

Symbion CEO, Brett Barons, said the PSA Excellence Awards are the pre-eminent individual awards in the industry.

 

“Being involved in these awards is one of the most enjoyable parts of my role, and this year will be Symbion’s 17^th straight year as award sponsor – we are extremely proud of our long association. 

 

“Our purpose at Symbion is to ‘connect communities to care’. This purpose is certainly consistent with what this year’s winners have always done. It is therefore wonderful to see that the rest of the community has recognised the incredible role Australian pharmacists are playing at the frontline,” Mr Barons said.  

 

Viatris Australia Country Manager, Sylvain Vigneault, said: “We are proud to sponsor the PSA Excellence Awards and celebrate the brilliant work that pharmacists do to look after the health of Australians. The awards are timely with World Pharmacists Day, and the theme this year – ‘Pharmacy: Always trusted for your health’ represents the challenging but incredible work of pharmacists over the course of the COVID-19 pandemic. We’re delighted to also sponsor the Pharmacy Student of the Year award and would like to extend our congratulations to Zoe Robinson for winning this award.”

 

Congratulations to the 2021 PSA Excellence Award winners, and Happy World Pharmacists Day to all of Australia’s pharmacists. 

 

 

Media contact: PSA media 0424 777 463

Victorian pharmacists recognised for a lifetime of service and legacy of achievement

The Pharmaceutical Society of Australia (PSA) has paid tribute to two Victorian pharmacists, Valerie Constable and John Ware OAM, for their significant service to Australian pharmacy, as dual recipients of the PSA Symbion Lifetime Achievement Award at today’s 2021 PSA Viatris Award Ceremony. 

 

For more than three decades, Valerie (Val) Constable has helped pave the way to optimise standards of pharmacy education and practice, becoming a trusted mentor to many.

 

A humble and highly regarded professional, Val was a leader for women in pharmacy. She was a preceptor, mentor, and role model to many and always made herself available to provide support and advice to any member of the profession who sought her wisdom or assistance. Val’s principles are epitomised by Pharmacists Support Services (PSS), the anonymous volunteer support service that she helped establish, and led for many years.

 

In 1991, Val was the first female in 135 years to be elected President of the PSA’s Victorian Branch. She rose above the glass ceiling through outstanding commitment, integrity, and professionalism. For over 35 years, Val and her husband Bob provided patient-centred care to their local communities through their pharmacies in Footscray and Pascoe Vale in Melbourne. She was a mentor to numerous trainees, many of whom have gone on to be prominent members of the profession.

 

Val recognised the need for greater structure in pharmacy training and worked with other pharmacists to establish the Chapter of Pharmacy Practice Tutors, and co-authored manuals on medical conditions treated through pharmacies. She was also a Board member of the National Asthma Campaign (precursor to the National Asthma Council), involved with educating pharmacists in asthma recognition and management, and development of the Asthma Management Plan. 

 

John Ware, former National President of PSA and State President of PSA’s Victorian Branch, received this award posthumously, following his passing in January this year. John also received the PSA Victorian Lifetime Achievement Award last year. 

 

He is a former President of the Australian College of Pharmacy Practice and Chair of the Faculty Council of the Victorian College of Pharmacy, Monash University. As Chair of the Victorian College of Pharmacy he led the team that integrated the monodisciplinary college of Pharmacy into a single faculty structure of Monash University. 

 

John was one of only a small number of Australians to have been awarded a Fellowship of the International Pharmaceutical Federation (FIP). He contributed globally in the field of Pharmacy including as President of the Western Pacific Pharmaceutical Forum and as President of the FIP Foundation.

 

Notably, John established the concept of pharmaceutical care for Australia, enhancing the role of pharmacists in medication management. John and his wife Nariel have established the Ware Fellowship, to invest in postdoctoral research into leadership in pharmacy education. 

 

PSA National President, A/Prof Chris Freeman, said: “Both Val and John have had such a tremendous impact on the profession, we made the decision to award the Lifetime Achievement Award to both of them this year. 

 

“John had demonstrated sustained dedication to the pharmacy profession and had been a driving force in the development and expansion of the role of the pharmacist in Australia.

 

“Val has been a trailblazer in her own right, forging the path for women in the profession to follow. She has been a mentor to many pharmacists and has made substantial gains for pharmacist involvement in respiratory care,” A/Prof Freeman said.

 

Chief Executive of Symbion, Brett Barons, said: “John’s family should be extremely proud of his contribution to pharmacy not only in Australia but also globally. Our purpose at Symbion is to connect communities to care. This is very much aligned with how John Ware lived his life. 

 

“Val should also feel extremely proud of the role she has played in being a true trailblazer for current and aspiring female pharmacists. She has shown that with persistence and a true ethos in helping others anything can be achieved. 

 

“The Symbion Lifetime Achievement Award is wonderful recognition of John and Val’s lifelong contribution to pharmacy, and I could not think of two more worthy recipients.”

 

Congratulations to Valerie and John, the 2021 Lifetime Achievement Award winners.

 

 

Media contact: PSA media 0424 777 463

Merimbula pharmacist awarded Pharmacist of the Year!

NSW South Coast pharmacist and pharmacy owner, Linda Badewtiz-Dodd, has claimed the prestigious PSA Symbion Pharmacist of the Year honour for 2021. 

 

This evening at the Pharmaceutical Society of Australia (PSA) Viatris Excellence Awards, the Merimbula-based pharmacist was recognised as an exemplar of the Australian pharmacy profession.

 

Linda is a shining example of a community pharmacist and pharmacy owner excelling in patient care, innovative professional practice, and community service. Her Merimbula pharmacy provides a wide range of services, including medication reviews, sleep apnoea services, and vaccinations to name just a few. Linda and her practice go above and beyond for their local community, providing high quality care and personalised support. 

 

Her strong community spirit and devotion to serving the Merimbula community was evidenced during the 2019 bushfires, when Linda provided emergency support to the town while her own home was under threat. During the crisis, Linda’s efforts supported the residents of nearby evacuated towns on the South Coast, including Eden and Bermagui, by mobilising face masks and essential medicines from Canberra. She continues to demonstrate her care for the community through the COVID-19 pandemic. 

 

Upon receiving the award, Ms Badewitz-Dodd said. “I’m just a pharmacist doing my thing, for my community and my customers – that’s what I do and that what a pharmacist is.

 

“We need, as a profession, to all step up. We need to all be providing a service that is part of an integrated healthcare model. Collaborating with other health professional and other allied health professionals is where we need to be if want to stay in this space.”

 

PSA National President, A/Prof Chris Freeman, said: “Linda exemplifies the extraordinary lengths that pharmacists have gone to ensure the public continued to have access to healthcare when they needed it the most. Linda puts the community first in everything she does, and I know, she will not let anything get in the way of that.

 

Chief Executive of Symbion, Brett Barons, said: “Symbion were very closely involved with many pharmacists impacted by the 2019 bushfires so we saw first-hand what Linda and her community experienced during that terrible time. It is wonderful that her service to her customers and the community spirit she clearly instils in Merimbula has been recognised with her being awarded the Symbion Pharmacist of the Year Award.”

 

Congratulations to Linda, the 2021 Pharmacist of the Year!

 

 

Media contact: PSA media 0424 777 463